Akums Drugs and Pharmaceuticals is into Healthcare & Pharmaceuticals Pharmaceutical and is looking raise funds through Fresh Issue and Offer For Sale
Akums Drugs and Pharmaceuticals IPO Update:
Akums Drugs And Pharmaceuticals Limited IPO: Delhi based Akums Drugs and Pharmaceuticals Limited established in the year 2004 and is into Healthcare & Pharmaceuticals - Pharmaceutical sector.
Company is promoted by Sanjeev Jain, Sandeep Jain, and Akums Master Trust. Pre-Offer Promoter and Promoter group stake in the company is 82.44%.
Akums Drugs and Pharmaceuticals Limited has filed Red Herring Prospectus (RHP) for proposed initial public offer (IPO). Total issue size is INR 1,857 Crores calculated on upper price band (face value of INR 2 per share) via initial public offering.
Initial Public Offer comprising of a Fresh Issue aggregating up to Rs. 680 crores and an Offer for Sale up to 17,330,435 Equity Shares.. ICICI Securities, ICICI Securities, Citigroup Global Markets India, Ambit have been appointed as lead merchant bankers for the proposed IPO. It has appointed Link Intime India Pvt. Ltd. as Registrar and Share transfer Agent.
Details about upcoming IPO:
As per the details available in RHP, Price band is Rs 646 to Rs 679 with lot size of 22 shares and in multiples thereof. Objects of the issue is 1) Repayment/prepayment of debt of the company and subsidiaries - Rs387 Cr, 2) Working Capital - Rs55 Cr 3) Pursuing inorganic growth initiatives through acquisitions and 4) General corporate purposes.
IPO Dates:
IPO will open on July 30, 2024 and close on July 30, 2024. Tentative date of listing on stock exchanges is August 06, 2024
Want to know more details about the IPO, please visit here Akums Drugs and Pharmaceuticals Limited
Source: SEBI, BSE, NSE, DRHP, Akums Drugs and Pharmaceuticals, Industry Data
Disclaimer: Above article only publishes details about the IPO and for educational purpose only. It doesn't solicit or invite any interest to invest in any kind of securities. Please visit respective sources to verify and know more details about the IPO. We advise investors to take opinion from certified/SEBI registered experts before taking any investment decisions.
0 Comments